Andrew Hall
Directeur Général chez G13r Ltd.
Profil
Andrew Hall is the founder of G13r Ltd.
founded in 2016.
He is currently a Venture Partner at Stone Ridge Ventures Pty Ltd.
since 2007.
Mr. Hall's former jobs include being the CEO of Bright Generation Pty Ltd.
from 2009 to 2013, Director of Founder Institute, Inc. from 2015 to 2018, Director of Australia's National Digital Health Initiative from 2017 to 2022, and Senior Advisor-Strategy, Growth & Financing at Inotek Pharmaceuticals Corp.
from 2005 to 2018.
Mr. Hall's education includes an undergraduate degree from The University of Western Australia in 1994 and a graduate degree from Wageningen University in 1999.
Postes actifs de Andrew Hall
| Sociétés | Poste | Début |
|---|---|---|
Stone Ridge Ventures Pty Ltd.
 Stone Ridge Ventures Pty Ltd. Investment ManagersFinance Stone Ridge Ventures Pty Ltd (Stone Ridge Ventures) is a venture capital firm founded in 2002 by Matthew Callahan and Robert Melville Newman. The firm is headquartered in Balcatta, Australia. | Private Equity Investor | 01/01/2007 |
| G13r Ltd. | Directeur Général | 01/01/2016 |
Anciens postes connus de Andrew Hall
| Sociétés | Poste | Fin |
|---|---|---|
Australia'S National Digital Health Initiative
 Australia'S National Digital Health Initiative Packaged SoftwareTechnology Services AndHealth is an Australian company that was founded in 2017 by Bronwyn Le Grice. The private company is based in Australia's National Digital Health Initiative. The company aims to provide programs and support to digital health companies in Australia, specifically addressing the challenges of commercializing in this new and emerging sector. Bronwyn Le Grice has been the CEO since incorporation. | Directeur/Membre du Conseil | 31/10/2022 |
Founder Institute, Inc.
 Founder Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Founder Institute, Inc. provides startup launch programs. Its curriculum include branding and design, product development, and equity and funding. The company was founded by Adeo Ressi and Jonathan Greechan in 2009 and is headquartered in San Francisco, CA. | Directeur/Membre du Conseil | 31/07/2018 |
Inotek Pharmaceuticals Corp.
 Inotek Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Inotek Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company. It focuses on the discovery, development and commercialization of therapies for glaucoma and other diseases of the eye. The company's product candidate includes Trabodenoson, an adenosine mimetic that has completed Phase II clinical trials for lowering IOP by restoring the eye's natural pressure control mechanism. It is also developing Trabodenoson plus Latanoprost, a prostaglandin analogue that has completed Phase II clinical trials for use in patients with inadequate responses to treatment with latanoprost; and Trabodenoson monotherapy for the treatment of optic nerve neuropathy. Inotek Pharmaceuticals was founded on July 7, 1999 by Csaba Szabo and Andrew L. Salzman and is headquartered in Lexington, MA. | Consultant / Advisor | 08/01/2018 |
| Bright Generation Pty Ltd. | Directeur Général | 31/03/2013 |
Formation de Andrew Hall
| The University of Western Australia | Undergraduate Degree |
| Wageningen University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Inotek Pharmaceuticals Corp.
Inotek Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Inotek Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company. It focuses on the discovery, development and commercialization of therapies for glaucoma and other diseases of the eye. The company's product candidate includes Trabodenoson, an adenosine mimetic that has completed Phase II clinical trials for lowering IOP by restoring the eye's natural pressure control mechanism. It is also developing Trabodenoson plus Latanoprost, a prostaglandin analogue that has completed Phase II clinical trials for use in patients with inadequate responses to treatment with latanoprost; and Trabodenoson monotherapy for the treatment of optic nerve neuropathy. Inotek Pharmaceuticals was founded on July 7, 1999 by Csaba Szabo and Andrew L. Salzman and is headquartered in Lexington, MA. | Health Technology |
Founder Institute, Inc.
Founder Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Founder Institute, Inc. provides startup launch programs. Its curriculum include branding and design, product development, and equity and funding. The company was founded by Adeo Ressi and Jonathan Greechan in 2009 and is headquartered in San Francisco, CA. | Commercial Services |
Stone Ridge Ventures Pty Ltd.
Stone Ridge Ventures Pty Ltd. Investment ManagersFinance Stone Ridge Ventures Pty Ltd (Stone Ridge Ventures) is a venture capital firm founded in 2002 by Matthew Callahan and Robert Melville Newman. The firm is headquartered in Balcatta, Australia. | Finance |
| Bright Generation Pty Ltd. | Industrial Services |
Australia'S National Digital Health Initiative
Australia'S National Digital Health Initiative Packaged SoftwareTechnology Services AndHealth is an Australian company that was founded in 2017 by Bronwyn Le Grice. The private company is based in Australia's National Digital Health Initiative. The company aims to provide programs and support to digital health companies in Australia, specifically addressing the challenges of commercializing in this new and emerging sector. Bronwyn Le Grice has been the CEO since incorporation. | Technology Services |
| G13r Ltd. |
